ENTITY

Cybin (CYBN CN)

5
Analysis
Health CareCanada
Cybin Inc. is a life sciences company. The Company focuses on psychedelic drug development, unique delivery mechanisms, improved novel compounds, and protocols. Cybin serves customers worldwide.
more
bullishCybin
20 Nov 2024 09:31Issuer-paid

Cybin, Inc. - CYB003 Demonstrates Exceptional Durable Treatment Benefits for Depression

CYB003 also demonstrated an excellent safety profile, with no new adverse events reported in the 12- month follow-up, including no reports of...

Logo
118 Views
Share
bullishCybin
15 Nov 2024 19:58Issuer-paid

Cybin, Inc - CYB003 Phase 3 Trial Initiated

Pivotal first study is underway, with top-line results expected in 2026. The first study (named APPROACH) is a two-arm study involving a targeted...

Logo
190 Views
Share
bearishCybin
05 Nov 2024 07:06Issuer-paid

Cybin, Inc. - Why Compass Pathways Is No Compass for Cybin's Progression Prospects

To conserve cash to fund its COMP360 program, Compass also announced a corporate restructuring involving the downsizing of staff by ~30% as well as...

Logo
929 Views
Share
bullishCybin
12 Oct 2024 07:28Issuer-paid

Cybin, Inc. - Potential of a Significant Paradigm Shift

Such an outcome could be a paradigm shift for the 68 million people in the US suffering from anxiety disorders (of which GAD is the most prevalent)

Logo
354 Views
Share
x